Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Koizumi Expresses Strong Commitment to Social Security Reform
October 10, 2005
- MOF Considering 2nd Medical Fee Cut in FY2006
October 10, 2005
- REGULATORY NEWS IN BRIEF
October 10, 2005
- Interim Report Presented to Improve Environments for IITs
October 10, 2005
- BUSINESS NEWS IN BRIEF
October 3, 2005
- SSP Aims to Quickly Recover Sales Lost Through Business Transfer
October 3, 2005
- NEW PRODUCTS
October 3, 2005
- OTC Drugs Less Potent in Japan Than in the West: Mr Hishikura of GSK
October 3, 2005
- OPINION
October 3, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 3, 2005
- Committee on Health Insurance to Discuss Revision of Medical Fee System
October 3, 2005
- SURVEY 3 articles
October 3, 2005
- GL Needed to Raise Awareness of Cost-effectiveness: Prof. Endo
October 3, 2005
- Patients Contribute to Better Treatment: Dr Nomura
October 3, 2005
- Flat-sum System for Chronic-stage Care Should Be Introduced at All Facilities: Prof. Ikegami
October 3, 2005
- REGULATORY NEWS IN BRIEF
October 3, 2005
- Nihon Medi-physics' FDGscan to Be Covered by Insurance Programs
October 3, 2005
- Cancer Patients' Groups Go into Action
October 3, 2005
- Is DWIBS Superior to PET?
October 3, 2005
- TOPICS 2 articles
October 3, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…